DD204256A5 - Verfahren zur herstellung von aminooxazolylverbindungen - Google Patents

Verfahren zur herstellung von aminooxazolylverbindungen Download PDF

Info

Publication number
DD204256A5
DD204256A5 DD82243550A DD24355082A DD204256A5 DD 204256 A5 DD204256 A5 DD 204256A5 DD 82243550 A DD82243550 A DD 82243550A DD 24355082 A DD24355082 A DD 24355082A DD 204256 A5 DD204256 A5 DD 204256A5
Authority
DD
German Democratic Republic
Prior art keywords
amino
lower alkyl
group
formula
methyl
Prior art date
Application number
DD82243550A
Other languages
German (de)
English (en)
Inventor
Riccardo Scartazzini
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of DD204256A5 publication Critical patent/DD204256A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD82243550A 1981-09-30 1982-09-28 Verfahren zur herstellung von aminooxazolylverbindungen DD204256A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH630381 1981-09-30
CH304982 1982-05-17
CH480782 1982-08-11

Publications (1)

Publication Number Publication Date
DD204256A5 true DD204256A5 (de) 1983-11-23

Family

ID=27174099

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82243550A DD204256A5 (de) 1981-09-30 1982-09-28 Verfahren zur herstellung von aminooxazolylverbindungen

Country Status (12)

Country Link
EP (1) EP0076452A3 (fi)
DD (1) DD204256A5 (fi)
DK (1) DK432582A (fi)
ES (1) ES8402592A1 (fi)
FI (1) FI823304L (fi)
GB (1) GB2106519B (fi)
GR (1) GR77677B (fi)
MA (1) MA19602A1 (fi)
NO (1) NO823291L (fi)
PT (1) PT75626B (fi)
RO (1) RO84457B (fi)
ZW (1) ZW20982A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten
JPS6197288A (ja) * 1984-10-19 1986-05-15 Kaken Pharmaceut Co Ltd セフアロスポリン化合物
US4698338A (en) * 1986-02-19 1987-10-06 Eli Lilly And Company 7[2-(2-aminothiazol-4-yl)-2-benzyloximino]acetamido-3[4-alkyl-5-oxo-6-hydroxy-3,4-dihydro-1,2,4-triazin-3-yl]thiomethyl cephalosporins
HUT53892A (en) * 1989-04-07 1990-12-28 Technologishen Kom Za Promy Mi Process for producing synaminothiazolyl and synaminooxazolyl derivatives
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
FR2068419A1 (en) * 1969-10-27 1971-08-27 Fujisawa Pharmaceutical Co Antibacterial cephalosporin compsns
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
CA1088049A (en) * 1975-06-03 1980-10-21 Takashi Masugi 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof
US4430499A (en) * 1981-09-08 1984-02-07 Eli Lilly And Company 7-[2-(2-Aminooxazol-4-yl)-2-(oximino)acetamido]cephalosporin antibiotics
US4382932A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company Isoquinolinium substituted cephalosporins
US4382931A (en) * 1981-09-08 1983-05-10 Eli Lilly And Company 3'-Substituted quinolinium cephalosporins
US4388316A (en) * 1981-10-02 1983-06-14 Eli Lilly And Company Amino-substituted oxazole, oxadiazole and isoxazole-substituted cephalosporins
US4379787A (en) * 1981-10-02 1983-04-12 Eli Lilly And Company Oximino-substituted cephalosporin compounds
EP0096297B1 (de) * 1982-06-03 1988-06-15 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-Sulfo-2-oxoazetidinderivaten

Also Published As

Publication number Publication date
PT75626B (de) 1985-12-09
FI823304L (fi) 1983-03-31
DK432582A (da) 1983-03-31
EP0076452A3 (de) 1984-09-05
RO84457A (ro) 1984-06-21
MA19602A1 (fr) 1983-04-01
GB2106519B (en) 1985-04-24
EP0076452A2 (de) 1983-04-13
RO84457B (ro) 1984-08-30
FI823304A0 (fi) 1982-09-27
GR77677B (fi) 1984-09-25
NO823291L (no) 1983-04-05
ZW20982A1 (en) 1983-04-27
PT75626A (de) 1982-10-01
GB2106519A (en) 1983-04-13
ES516013A0 (es) 1984-02-01
ES8402592A1 (es) 1984-02-01

Similar Documents

Publication Publication Date Title
DE2129675A1 (de) Antibiotika und Verfahren zu deren Herstellung
DD201906A5 (de) Verfahren zur herstellung von 7 beta-aminothiadiazolylacetylamino-3 ammoniomethyl-3-cephem-4-carbonsaeureverbindungen
EP0009008A2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2331148C2 (de) 7-Amino-cepham-3-on-4-carbonsäureverbindungen
EP0016296A1 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung, diese enthaltende Präparate und Zwischenprodukte sowie deren Herstellung
DD152788A5 (de) Verfahren zur herstellung von polyazathiaverbindungen
DD204256A5 (de) Verfahren zur herstellung von aminooxazolylverbindungen
DE2636962C2 (fi)
DE2637176A1 (de) Carbonylmethylderivate
EP0000500B1 (de) Cephalosporinderivate, Verfahren zu deren Herstellung und deren pharmazeutische Präparate
EP0022245A2 (de) Amino-thiadiazolyl-Verbindungen, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Präparate; Ausgangsverbindungen und Verfahren zu ihrer Herstellung
EP0015240A1 (de) Azacyclyl (thio) ureidoacetyl-Verbindungen und Verfahren zu ihrer Herstellung
DE2448582A1 (de) Verfahren zur herstellung von cephalosporinen
EP0037797A2 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung, sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung
EP0008343A1 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2846713A1 (de) Cephalosporine, ihre herstellung und sie enthaltende arzneimittel
EP0031794A2 (de) Cephalosporinderivative, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE2333263A1 (de) 7 beta-amino-3-oximinomethyl-cephem-4carbonsaeureverbindungen und verfahren zu ihrer herstellung
EP0059683A2 (de) 7-Acylamido-3-cephem-4-carbonsäureverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren
DE3518848A1 (de) Aminoaethylthioverbindungen
DD207720A5 (de) Verfahren zur herstellung von 7 beta-acylamido-3-cephem-4-carbonsaeureverbindungen
CH605999A5 (en) 3-Thio-7-amino-3- and-2-cephem-4-carboxylic acids
EP0121499A2 (de) 7Beta-Acylamido-3-cephem-4-carbonsäureverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren
DE3326194A1 (de) Aminoimidazolyl-verbindungen, verfahren zu ihrer herstellung, pharmazeutische praeparate, welche diese vrbindungen enthalten, und verwendung von letzteren
AT353971B (de) Verfahren zur herstellung von neuen, eine niederalkylsulfonylaminogruppe enthaltenden cephalosporinen